Pfizer, Apotex Agree To Settle Over Lipitor
Pfizer Inc. has agreed to settle its patent lawsuit against Canadian drugmaker Apotex Inc., possibly ending the fight over the production of the generic versions of Pfizer's blockbuster cholesterol-reducing drug, Lipitor....To view the full article, register now.
Already a subscriber? Click here to view full article